文献速递艾滋病与性传播感染

社区药师与HIV临床提供者协作的患者中心HIV照护模型:依从性与病毒抑制

Adherence and Viral Suppression Among Participants of the Patient-centered Human Immunodeficiency Virus (HIV) Care Model Project: A Collaboration Between Community-based Pharmacists and HIV Clinical Providers.
PubMed 文献 · Clin Infect Dis · 2020-01-01

患者中心HIV照护模型将社区药师与HIV医疗提供者整合,要求共享临床信息、识别治疗相关问题并制定行动计划。在765名入组参与者中,实施模型前后抗逆转录病毒治疗依从比例(PDC≥90%)保持不变,但病毒抑制(HIV RNA<200 copies/mL)相对改善15%(75%至86%,P<.001)。较高的PDC和基线病毒抑制与实施后病毒抑制相关。

要点

  • 该模型整合社区药师与HIV临床提供者,可能识别并解决治疗相关问题。
  • 实施后病毒抑制相对改善15%(75%至86%,P<.001)。
  • 非西班牙裔黑人病毒抑制相对改善23%(63%至78%,P<.001)。

核心结论

  • 社区药师与初级医疗提供者整合照护模型可能识别并解决HIV治疗相关问题,改善HIV感染者病毒抑制。

研究设计与样本

  • 患者中心HIV照护模型整合社区药师与HIV医疗提供者,要求共享临床信息、识别治疗相关问题并制定行动计划。
  • 765名入组参与者中,421名纳入依从性分析,649名纳入病毒抑制分析。

主要发现

  • 总体依从比例保持不变。
  • 病毒抑制相对改善15%(75%至86%,P<.001)。
  • 较高PDC(每增加1个PDC类别AOR 1.74,95%CI 1.30-2.34)和基线病毒抑制(AOR 7.69,95%CI 3.96-15.7)与实施后病毒抑制相关。

关键数值与推荐

  • 依从定义为PDC≥90%。
  • 病毒抑制定义为HIV RNA<200 copies/mL。
  • PDC分层为<50%、50%至<80%、80%至<90%和≥90%。

临床怎么用

  • 社区药师与HIV临床提供者整合照护模型可用于识别和解决HIV治疗相关问题以改善病毒抑制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human immunodeficiency virus (HIV) viral suppression (VS) decreases morbidity, mortality, and transmission risk. METHODS: The Patient-centered HIV Care Model integrated community-based pharmacists with HIV medical providers and required them to share patient clinical information, identify therapy-related problems, and develop therapy-related action plans.Proportions adherent to antiretroviral therapy (proportion of days covered [PDC] ≥90%) and virally suppressed (HIV RNA <200 copies/mL), before and after model implementation, were compared. Factors associated with postimplementation VS were determined using multivariable logistic regression; participant demographics, baseline viral load, and PDC were explanatory variables. PDC was modified to account for time to last viral load in the year postimplementation, and stratified as <50%, 50% to <80%, 80% to <90%, and ≥90%. RESULTS: The 765 enrolled participants were 43% non-Hispanic black, 73% male, with a median age of 48 years; 421 and 649 were included in the adherence and VS analyses, respectively. Overall, proportions adherent to therapy remained unchanged. However, VS improved a relative 15% (75% to 86%, P < .001). Higher PDC (adjusted odds ratio [AOR], 1.74 per 1-level increase in PDC category [95% confidence interval {CI}, 1.30-2.34]) and baseline VS (AOR, 7.69 [95% CI, 3.96-15.7]) were associated with postimplementation VS. Although non-Hispanic black persons (AOR, 0.29 [95% CI, .12-.62]) had lower odds of suppression, VS improved a relative 23% (63% to 78%, P < .001). CONCLUSIONS: Integrated care models between community-based pharmacists and primary medical providers may identify and address HIV therapy-related problems and improve VS among persons with HIV.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Byrd KK, Hou JG, Bush T, et al. Adherence and Viral Suppression Among Participants of the Patient-centered Human Immunodeficiency Virus (HIV) Care Model Project: A Collaboration Between Community-based Pharmacists and HIV Clinical Providers. Clin Infect Dis. 2020. PMID: 30953062. doi:10.1093/cid/ciz276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。